PCI The Journeys Within
CPHI 2026 – 23/07/2026
Media Pack
News

Current Edition

Volume 18 Issue 2
ramusmedical
news

PCI Pharma Services Announces Agreement to Acquire Sherpa Clinical Packaging

PCI Expands Clinical Services’ presence with acquisition of California-based Sherpa Clinical Packaging Philadelphia, USA – September 10, 2018 Leading global biopharm...
21 September 2018 news | North America | Regional News | Uncategorized
Continue Reading →
news

PCI Announces Expansion of its Industry-Leading Cold Chain Infrastructure with Dedicated -40°C Facility

PCI Clinical Services purpose-built state-of-the-art Cold Chain facility opens in Rockford, IL Philadelphia, USA – August 29, 2018 PCI Pharma Services (PCI), a full-...
21 September 2018 news | North America | Regional News
Continue Reading →
Europe

Alector announces initiation of Phase 1 trial of AL001 for treating frontotemporal dementia

Alector, a privately held biotechnology company pioneering immuno-neurology, a novel therapeutic approach for the treatment of neurodegeneration, today announced the ...
20 September 2018 Europe | news | Regional News
Continue Reading →
news

Novel clinical trial to examine cannabis as potential treatment for essential tremor

Researchers at University of California School of Medicine are preparing to launch a novel clinical trial to examine the safety, efficacy and pharmacological properti...
20 September 2018 news | North America | Regional News
Continue Reading →
MEANA Region

Resveratrol decreases pain severity and levels of inflammatory biomarkers in osteoarthritis patients

In what researchers state is the first pilot clinical trial to assess the effects of resveratrol on pain severity and levels of inflammatory biomarkers in patients wi...
20 September 2018 MEANA Region | news | Regional News
Continue Reading →
Europe

Landmark MS trial launches in UK

  The biggest ever trial for secondary progressive multiple sclerosis (SPMS) has kicked off in the UK at around 30 sites in England, Scotland, Wales, Northern I...
20 September 2018 Europe | news | Regional News
Continue Reading →
Europe

The Lancet Respiratory Medicine publishes first Phase III trial for PT010 triple combination therapy in moderate to very severe chronic obstructive pulmonary disease

AstraZeneca today announced publication of results from the KRONOS Phase III trial which evaluated the efficacy and safety of triple combination therapy PT010 (budeso...
20 September 2018 Europe | news | Regional News
Continue Reading →
Australasia

Study finds daily aspirin does not reduce heart attack risk

Daily, low dose asprin found to not minimise heart attack risk. Monash University in Australia has repo...
20 September 2018 Australasia | news | North America | Regional News
Continue Reading →
Europe

Positive Phase 3 results presented for Dupixent® (dupilumab) show significant improvement on multiple measures of disease severity in adolescents with moderate-to-severe atopic dermatitis

Results on skin clearing, itch and certain quality of life measurements were presented today as a late-breaking oral presentation at the 27th EADV Congress   Par...
20 September 2018 Europe | news | North America | Regional News
Continue Reading →
Europe

Alzheimer’s disease: amyloid β protein once again in the spotlight as a therapeutic target

World Alzheimer's Day on 21 September 2018 (Vienna, 18 September 2018) For many years amyloid β protein was considered to be a promising therapeutic target in Alz...
20 September 2018 Europe | news | North America | Regional News
Continue Reading →
Quotient
CPHI 2026 – 20/07/2026
jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2026, All Rights Reserved – Powered by Teksyte